Intestinal subtype as a biomarker of response to neoadjuvant immunochemotherapy in locally advanced gastric adenocarcinoma: insights from a prospective phase II trial.
Wang L, Sun M, Li J, Wan L, Tan Y, Tian S, Hou Y, Wu L, Peng Z, Hu X, Zhang Q, Huang Z, Han M, Peng S, Pan Y, Ren Y, Zhang M, Chen D, Liu Q, Li X, Qin ZY, Xiang J, Li M, Zhu J, Chen Q, Luo H, Wang S, Wang T, Li F, Bian XW, Wang B.
Wang L, et al. Among authors: huang z.
Clin Cancer Res. 2024 Nov 4. doi: 10.1158/1078-0432.CCR-24-2436. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39495175